PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
4.76%
Net income growth under 50% of AVGO's 78.75%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-8.42%
Both reduce yoy D&A, with AVGO at -2.34%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
202.00%
Some yoy growth while AVGO is negative at -15900.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-12.12%
Negative yoy SBC while AVGO is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
51.38%
Slight usage while AVGO is negative at -111.11%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
776.60%
AR growth while AVGO is negative at -10350.00%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-29.82%
Both reduce yoy inventory, with AVGO at -105.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
104.17%
Lower AP growth vs. AVGO's 379.31%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-85.61%
Negative yoy usage while AVGO is 5400.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-1175.00%
Both negative yoy, with AVGO at -55.81%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
1.49%
Some CFO growth while AVGO is negative at -1.69%. John Neff would note a short-term liquidity lead over the competitor.
-17.99%
Negative yoy CapEx while AVGO is 28.38%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
17.99%
Less M&A spending yoy vs. AVGO's 100.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-129.63%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-55.41%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
56.06%
Growth of 56.06% while AVGO is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-273.52%
We reduce yoy invests while AVGO stands at 88.19%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-33.33%
We cut debt repayment yoy while AVGO is 98.99%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
214.29%
We slightly raise equity while AVGO is negative at -1.79%. John Neff sees competitor possibly preserving share count or buying back shares.
20.63%
Buyback growth of 20.63% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.